Details for New Drug Application (NDA): 075103
✉ Email this page to a colleague
NDA 075103 describes CODAMINE, which is a drug marketed by Alpharma Us Pharms and is included in one NDA. Additional details are available on the CODAMINE profile page.
The generic ingredient in CODAMINE is hydrocodone bitartrate; phenylpropanolamine hydrochloride. There are twenty-three drug master file entries for this compound. Additional details are available on the hydrocodone bitartrate; phenylpropanolamine hydrochloride profile page.
The generic ingredient in CODAMINE is hydrocodone bitartrate; phenylpropanolamine hydrochloride. There are twenty-three drug master file entries for this compound. Additional details are available on the hydrocodone bitartrate; phenylpropanolamine hydrochloride profile page.
Summary for 075103
| Tradename: | CODAMINE |
| Applicant: | Alpharma Us Pharms |
| Ingredient: | hydrocodone bitartrate; phenylpropanolamine hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SYRUP;ORAL | Strength | 5MG/5ML;25MG/5ML | ||||
| Approval Date: | Sep 29, 2000 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
